Binding Molecules in Tick Saliva for Targeting Host Cytokines, Chemokines, and Beyond
Author Information
Author(s): Desidério Chamberttan Souza, Flávio-Reis Victor Hugo Palhares, Pessoa-Gonçalves Yago Marcos, Tiveron Rafael Destro Rosa, Sales-Campos Helioswilton, Felice Andrei Giacchetto, Soares Siomar de Castro, Guillermo-Ferreira Rhainer, Rodrigues Wellington Francisco, Oliveira Carlo José Freire
Primary Institution: Federal University of Triângulo Mineiro, Uberaba, Brazil
Hypothesis
What is the current state of the art in the literature on binding molecules found in tick saliva, including their specific targets and associated biological actions?
Conclusion
Tick saliva contains a diverse array of binding molecules that can modulate the host's immune response, potentially leading to new therapeutic applications.
Supporting Evidence
- Ticks have evolved to evade host immune responses through their saliva.
- Salivary molecules can inhibit key immune system components, aiding in prolonged feeding.
- Research indicates that tick saliva contains over 60 binding molecules with various targets.
- Evasins are a prominent class of molecules that bind to chemokines, reducing inflammation.
- Understanding these molecules could lead to new immunomodulatory therapies.
- Many tick species produce unique salivary proteins that modulate host immune responses.
- Future studies are needed to explore the full potential of these salivary molecules.
Takeaway
Ticks have special proteins in their saliva that help them feed by tricking the host's immune system, which could help scientists create new medicines.
Methodology
A narrative review was conducted following PRISMA guidelines, summarizing existing literature on binding molecules in tick saliva.
Limitations
Many binding molecules remain uncharacterized, and the mechanisms of action for several are still poorly understood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website